LXR inverse agonists for treatment of cancer
Abstract:
In some aspects, the present disclosure provides compounds of the formula: (I) or (II) wherein the variables are as defined herein. In some embodiments, these compounds may be used to treat cancer or other hyperproliferative diseases, as well as atherosclerosis and coronary artery disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0